Fuente: Labiotech Lugar: Sponsored As biologics grow more complex, Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that cut risk and speed development.
The post On the fast track to the clinic: early decisions in drug development appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.